Efficacy and Safety of Switching to High-intensity Statin in Thai Type 2 Diabetic Patients who had Achieved LDL-C Target with Low-dose Statins

Phase 3

Completed

• Conditions: type 2 diabetes with dyslipidemia; high- intensity statin, primary prevention, type 2 diabetes

• Registration Number: TCTR20180812001
• Lead Sponsor: Siriraj research grant

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2018-01-26
• Study Start: 2018-08-12
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

type 2 diabetes on simvastatin up to 20 mg/day, LDL<100 mg/dl

Exclusion Criteria

allergic to atorvastatin, chronic kidney disease, atherosclerotic vascular disease, active liver disease

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
safety of effiacacy 12 wk clinical and lab parameters

Secondary Outcome Measures

Name	Time	Method
pleiotropic effect of high-intensity statin 12 wk lab parameters